Marie Schneegans
FounderCo-founder GloGlo.com
Browser storage is unavailable. Keep this page open and export your collection before leaving.

Our mission: eradicate type 1 diabetes.
GloGlo is building an AI-native therapeutics company focused on accelerating the discovery of treatments that can prevent, stop, and ultimately cure type 1 diabetes.
We are developing AI research agents that continuously analyze scientific literature and biological datasets, generate and challenge hypotheses, design experiments, and run them in a wet lab to learn from experimental results.
We are building a tight "in silico <> in vitro/vivo" feedback loop that helps us identify better targets, run experiments more efficiently, and move faster toward therapies for type 1 diabetes.
Previously Markprompt, 14.ai
Co-founder GloGlo.com
Co-founder GloGlo.com. Previously, co-founder of Snips (AI voice platform, acquired by Sonos). Maths at Cambridge.
Founded 2024 · Source
Source-based assessment · automated evidence rules
The homepage contains prelaunch or closure language; availability needs review.
Maturity is an evidence-based assessment, not a success rating. It may understate the current stage where evidence is limited. Coverage records documented areas, not a complete or independently audited company history.